PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 20 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $354,000 | +2.6% | 400,000 | 0.0% | 0.09% | +17.8% |
| Q2 2022 | $345,000 | -2.5% | 400,000 | 0.0% | 0.07% | +19.7% |
| Q1 2022 | $354,000 | -3.3% | 400,000 | 0.0% | 0.06% | +17.3% |
| Q4 2021 | $366,000 | +3.7% | 400,000 | 0.0% | 0.05% | +2.0% |
| Q3 2021 | $353,000 | -1.1% | 400,000 | 0.0% | 0.05% | +6.2% |
| Q2 2021 | $357,000 | -0.3% | 400,000 | 0.0% | 0.05% | -5.9% |
| Q1 2021 | $358,000 | +3.2% | 400,000 | 0.0% | 0.05% | +4.1% |
| Q4 2020 | $347,000 | +5.5% | 400,000 | 0.0% | 0.05% | -14.0% |
| Q3 2020 | $329,000 | +1.9% | 400,000 | 0.0% | 0.06% | +9.6% |
| Q2 2020 | $323,000 | +22.8% | 400,000 | 0.0% | 0.05% | +20.9% |
| Q1 2020 | $263,000 | -8.0% | 400,000 | 0.0% | 0.04% | +48.3% |
| Q4 2019 | $286,000 | +2.1% | 400,000 | 0.0% | 0.03% | +3.6% |
| Q3 2019 | $280,000 | +2.6% | 400,000 | 0.0% | 0.03% | +7.7% |
| Q2 2019 | $273,000 | – | 400,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |